NUZOLVENCE

This brand name is authorized in United States.

Active ingredients

The drug NUZOLVENCE contains one active pharmaceutical ingredient (API):

`1`	Zoliflodacin UNII `FWL2263R77` - ZOLIFLODACIN
	Zoliflodacin is an antibacterial drug. It is a spiropyrimidinetrione inhibitor of the bacterial type II topoisomerases (DNA gyrase and topoisomerase IV), which are required for DNA synthesis. Zoliflodacin binds within the cleaved DNA–gyrase complex, blocking re-ligation, and interacts with conserved amino acids in the gyrase B subunit.
	Read more about Zoliflodacin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NUZOLVENCE Oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	68547-915

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.